AUS
NZ
UK
CA
USA
IND
Healthcare
Medlab Reports Significant Improvement In NanoStat™ Compared To Orally Ingested 20 mg Tablet, Atorvastatin
January 09, 2019 04:53 PM AEDT| By Team Kalkine MediaOn 9 January 2019, Medlab Clinical Ltd (ASX: MDC) announced that it has successfully analyzed the results of the NanoStat? bioequivalence trial from Zenith in New Zealand. Although the price of the scrip is trending down from past six months falling...
3 Biotech Stocks Up Today - RVA, IMU And VHT
January 08, 2019 08:01 PM AEDT| By Team Kalkine MediaAfter rallying from a loss in the morning session today as at January 08, 2018, ASX has reached to a month-long high. The Australian biotech market is expected to see growth to ~$25 billion which is currently valued at $23 billion. Australia is ranke...
Telix Pharmaceuticals Ramps Up Its Cancer Therapy Program
January 08, 2019 07:47 PM AEDT| By Team Kalkine MediaBiopharmaceutical player Telix traded at higher levels after the company unveiled the strategy update for its Prostate Cancer Therapy Program. Telix Pharmaceuticals Limited (ASX: TLX) stated that the data analysis and independent monitoring by a thi...
Mesoblast Limited Highlighted Its Commercial And Development Plans At Biotech Showcase 2019
January 08, 2019 07:39 PM AEDT| By Team Kalkine MediaRegenerative medicine company, Mesoblast Limited (ASX: MSB) recently highlighted the commercial and development plans for its lead cellular therapies at the first day of Biotech Showcase 2019 which is being held this week in San Francisco, California...
Oventus Uncovers Next-Generation Oral Device, Stock Up 11%
January 08, 2019 05:26 PM AEDT| By Team Kalkine MediaHealthcare company Oventus Medical Limited wheels the launch of O2Vent? Optima oral device in Australia aimed at the treatment of sleep apnoea. The news sent the OVN stock price to jump up by 11.667% to trade at $0.335 on 8 January 2019 (2:19 PM AEST...
Shares Of Biotech Player Patrys Zoom Up On Receiving R&D Tax Incentive Refund
January 08, 2019 03:19 PM AEDT| By Team Kalkine MediaAs per ASX release dated 8 January 2019, biotechnology player, Patrys Limited (ASX: PAB) announced obtaining $556,129 R&D Tax Incentive Refund for FY 2018 by the Australian Government. R&D Tax Incentive Refund offers refundable tax rebate of...
MMJ Group’s Subsidiary MediPharm Labs Commences Trading in the U.S. on OTCQB Market
January 08, 2019 02:50 PM AEDT| By Team Kalkine MediaGlobal Cannabis Investment Company, MMJ Group Holdings Limited (ASX: MMJ) currently owns around 4.4 million shares for a 4.5 percent shareholding and 2.9 million warrants in Canada?s leading cannabis-focused pharmaceutical company, MediPharm Labs Inc...
The Share Price of RVA Zoomed Up By 21.212% After Its Geographical Expansion Update.
January 07, 2019 11:55 PM AEDT| By Team Kalkine MediaREVA Medical, Inc. (ASX: RVA), a medical device company who is also the leader of bioresorbable polymer technologies announced its geographical expansion in seven European countries along with four new distribution partners. Through this partnership,...
Prana Biotechnology Presents the Treatment of Neurological Disorder – What You Need to Know
January 07, 2019 11:00 PM AEDT| By Team Kalkine MediaPrana Biotechnology Limited (ASX: PBT) is in the healthcare industry develops first-in-class therapies for neurodegenerative diseases to treat orphans. The company has a vast experience in research, pharmaceutical, and financial industries along with...
Creso Pharma Is Set To Enter Sri Lanka’s Medicinal Cannabis Industry
January 07, 2019 07:10 PM AEDT| By Team Kalkine MediaAs per ASX announcement dated 7 January 2019, Creso Pharma Limited (ASX: CPH) has signed a Letter of Intent with Ceyoka Health Private Limited, Srilanka?s leading medical distribution company, for geographical expansion of medicinal cannabis across t...
Immutep Limited Enters Into Clinical Trial Collaboration
January 07, 2019 05:45 PM AEDT| By Team Kalkine MediaTo test eftilagimod alpha as part of a cancer peptide vaccine discovered by artificial intelligence new clinical trial collaboration with CYTLIMIC has been performed. With their cancer vaccine product candidate including efti, it builds on Immutep Li...
Kazia’s Presentation To Biotech Showcase Stated Achievement Of All Milestones For 2018– A Quick Look
January 07, 2019 04:52 PM AEDT| By Team Kalkine MediaKazia Therapeutics Limited (ASX: KZA) operates as a biotechnology company. The Company develops anti-cancer drugs, as well as provides pharmaceutical research and development technology solutions. Kazia Therapeutics serves customers globally. The co...
Cynata Therapeutics Got Notice Of Acceptance From IP Australia For Cymerus Patent Application
January 07, 2019 03:18 PM AEDT| By Team Kalkine MediaOn 7 January 2019, Cynata Therapeutics (ASX: CYP) came forward and made an announcement about the Notice of Acceptance which it had got from IP Australia. Dr. Paul Wotton is presently acting as the company's Chairman while Dr. Ross Macdonald is actin...
Healius Board Rejected Jangho Hong Kong’s Acquisition Proposal – What You Need To Know
January 07, 2019 03:07 PM AEDT| By Team Kalkine MediaFormerly known as Primary Health Care Ltd, Australia's leading healthcare company Healius Limited (ASX: HLS) has rejected the acquisition proposal from Jangho Hong Kong Holdings Limited. Following this news, the share price of HLS decreased by 5.818...
Mesoblast’s Stock Soars On ASX Following The Completion Of Patient Recruitment In Phase Three Trial
January 07, 2019 02:13 PM AEDT| By Team Kalkine MediaMesoblast Limited (ASX: MSB) is into innovation of cellular medicines. It develops off the shelf cellular drugs.? It has a diversified portfolio of cell-based and most clinically advanced products. The company has its technology platform of mesenchym...
Bionomics Begins The Clinical Trial Of Cancer Drug BNC105
January 04, 2019 07:21 PM AEDT| By Team Kalkine MediaBionomics Limited (ASX: BNO) is a bio-pharma company under the health care sector based out in Thebarton, Australia. The company is engaged in developing better treatments for cancer, central nervous system disorders (including anxiety and depression...
GI Dynamics Appointed New Vice President of Clinical and Regulatory Affairs
January 04, 2019 07:10 PM AEDT| By Team Kalkine MediaMedical device company, GI Dynamics Inc (ASX:GID) has appointment highly experienced Mr. Stephen Linhares as the new Vice President of clinical and regulatory affairs. As Vice President of clinical and regulatory affairs at GI Dynamics, Mr. Linhares...
REVA Medical Announces New CFO
January 04, 2019 07:10 PM AEDT| By Team Kalkine MediaOn January 4, 2019, REVA Medical, Inc. (ASX: RVA) has made a public announcement that Ms. Leigh Elkolli will become a new CFO (Chief Financial Officer) and Corporate Secretary, which will be effective from today. Earlier Brandi Roberts held the posit...
Capitol Health: Daily Share Buyback Update
January 04, 2019 04:04 PM AEDT| By Team Kalkine MediaCapitol Health Ltd (ASX: CAJ) is a leading player in the Australian healthcare market segment, offering diagnostic image services via clinics established in Tasmania, Melbourne and Victoria. As per an ASX announcement dated 18 August 2017, Capitol H...
Resonance Health Soars On Acquiring The Use Of Licensed Patents
January 03, 2019 11:12 PM AEDT| By Team Kalkine MediaResonance Health shares sky-rocketed after the company announced the execution of license agreement for the use of patents. The stock price jumped as high as 54.098% to last trade at $0.094 on 3 January 2019. And if the stock continues to move with t...
Advertise your brand on Kalkine Media